Informatics firm inks deal with GOSH

● Ten-year tie-up set to ‘transform’ research offering at children’s hospital

very much looking forward to working with them on this next stage of their research journey.”

Peter Steer, chief executive of GOSH NHS Foundation Trust said: “We look forward to working with Aridhia to develop an innovative platform which will transform the way we undertake and collaborate on research.

“This will allow us to bring more life-saving treatments to children with rare diseases in the UK and worldwide.”

The trust in February said Aridhia had been selected as preferred supplier for the research and innovation platform. “This will drive our ability to translate research into clinical practice to further the development of life-changing treatments and cures,” the trust said at the time.

Aridhia was founded in 2007 and Roche told The Scotsman earlier this year that it had been investing in research and development in its platform, which was built for biomedical research, precision medicine and healthcare communities.

Roche, who joined in 2014, also said he was concentrating on the firm’s growth and maximising efficiency, adding that a key benefit of his role was the chance to have “a profound impact on clinical research at scale”.